Healthcare -
Biotechnology - NYSE - US
$ 13.9616
0.371 %
$ 802 M
Market Cap
-1.08
P/E
DNA - STOCK-BASED COMPENSATION
Stock-based Compensation DNA - Ginkgo Bioworks Holdings, Inc.
230 M
LAST VALUE
-62.17%
2 YEAR CAGR
-34.66%
5 YEAR CAGR
0.00%
10 YEAR CAGR